COVID-19 Maternal and Infant Health Research Registries

Research is critical to tracking the impact of COVID-19 on maternal and infant health. By collecting clinical and survey data from pregnant women and babies following the COVID-19 pandemic, we can enhance and develop programs and policies that improve care now and in the future.

Click on the links below to learn about the COVID-19 registries open to pregnant women and newborns who meet certain inclusion criteria.

Based in the United States:

University of California San Diego/Organization of Teratology Information Specialists (OTIS):

MothertoBaby Registry

  • This registry is part of an observational research study that examines the short and long-term effect of COVID-19 in pregnancy and while breastfeeding. The research takes place via phone calls throughout pregnancy and post- delivery and may ask for breastmilk samples and medical records related to the pregnancy.
  • Inclusion criteria: Currently pregnant, a resident of Canada or the U.S., and has known or suspected COVID-19 infection at any point in pregnancy or within 30 days of the last menstrual period before pregnancy.

University of Illinois at Chicago:

Covid-19 Pregnancy and Postpartum Experiences (COPE) Study

  • This registry from the University of Illinois at Chicago aims to understand how isolation, stress and changes in healthcare related to COVID-19 affect pregnancy and the postpartum period. Participation includes a 20- minute, anonymous survey.
  • Inclusion criteria: Women who are currently pregnant or have given birth since January 2020, at least 18 years old, able to read English and are in the United States

American Academy of Pediatrics:

Section on Neonatal Perinatal Medicine (SONPM) National Registry

  • This National Registry represents a collaboration between the American Academy of Pediatrics, Section on Neonatal-Perinatal Medicine (SONPM), the Vermont-Oxford Network (VON), and MedNAX (an organization of private neonatologists). This registry focuses on relative risks of transplacental, perinatal and postnatal transmission of COVID-19. The registry will provide population data on mother-infant dyads with the participation of hospitals around the US. The focus of the data collected will be for the perinatal community. Once the registry reaches 25 mother/infant dyads, real-time descriptive data will be available weekly on the SONPM website.
  • Inclusion criteria: Open to every hospital that takes care of infants. Must be able to submit de-identified maternal and neonatal data.

Women’s Hospital of Baton Rouge, Louisiana:

Pregnant During COVID-19 Survey Study

  • This study aims to gather data on how the COVID-19 pandemic is affecting pregnant women's health, feelings, behaviors and home/work situations. Participation includes weekly surveys and wellness check-ins. After birth, you may choose to link your responses to your baby's medical records.
  • Inclusion criteria: Pregnant women who are at least 18 years old.

Registries outside the United States:

Lausanne University Hospital:

International COVID-19 Registry and Pregnancy Registry (COVI-PREG)

  • This registry collects data to that will help better characterize the risks associated with COVID-19 infection during pregnancy for moms, fetuses and newborns through their physicians. This also will inform the creation of a responsive data system through a healthcare facilities network to ensure a rapid assessment of risks linked to future emergent pathogens.
  • Inclusion criteria: Pregnant women, who are at least 18 years old, have consented to the registry and are believed to have COVID-19.

University of Oxford:

COVID-19 in Pregnancy

  • This study is using the UK Obstetric Surveillance System (UKOSS) to determine the incidence of hospitalization due to COVID-19 in pregnancy and assess the outcomes of the pandemic for mothers and infants. This study will also look at the effects of treatments.
  • Inclusion criteria: Any woman admitted to a participating hospital in the UK with confirmed COVID-19 infection in pregnancy between the ages of 16-45. The surveillance period is March 1, 2020 - March 31, 2022.

The Global Health Network:

INTERCOVID: A prospective cohort study of the effects of COVID-19 in pregnancy and the neonatal period

  • This is a cohort study, coordinated by the University of Oxford, with the goal of assessing the effects of COVID-19 in pregnancy on maternal, fetal and neonatal outcomes worldwide. They are using an exposed and unexposed group to compare outcome differences and are monitoring their care until discharged from the hospital post-delivery. Primary outcomes will be categorized into a 'maternal morbidity index' and/or a 'severe neonatal morbidity index'.
  • Inclusion criteria: Pregnant women with a laboratory confirmed COVID-19 or radiological pulmonary findings suggestive of COVID-19 or maternal symptoms compatible with COVID-19 or absence of symptoms but in close interaction with a confirmed case of COVID-19.

Imperial College London: PAN-COVID:

Pregnancy and Neonatal Registry

  • This research will explore the experience of COVID-19 as well as miscarriage, fetal growth restriction and stillbirth, pre-term delivery and transmission from mother to baby. This international registry provides weekly data to health care communities and is available to the public online.
  • Inclusion criteria: Pregnant women who are suspected to have COVID-19 or confirmed COVID-19 infection. Women will be recruited through their health care provider.